Influenza News and Research

Latest Influenza News and Research

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

Analysis of the seasonality of common human coronaviruses

A new study published in the Emerging Infectious Diseases journal aimed to analyze the circulation of four common HCoVs from July 2014 to November 2021 in the US.

31 Aug 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

Researchers recently assessed the infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 variant compared to preexisting variants.

30 Aug 2022

COVID-19 may provoke IgA-associated vasculitis

In a new study, scientists showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes immunoglobulin A (IgA)-associated vasculitis (IgAV).

30 Aug 2022

Disrupting a virus’s genome packaging can halt replication, study finds

Like savvy international travelers, viruses know exactly how to pack. With the genetic instructions for the next generation folded just so, snuggled into a custom-made outer covering studded with cell-grabbing proteins, these tiny invaders quest for new digs on the reg.

30 Aug 2022

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

Researchers performed a structural bioinformatics analysis to evaluate the binding energy of the SARS-CoV-2 Omicron variants of concern spike protein receptor-binding domain to human angiotensin-converting enzyme 2 receptor compared to other VOCs.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

The Institute for Basic Science recently visited the National Institutes of Health and announced its collaboration with St. Jude Children's Research Hospital in the U.S., with the aims of increasing virus research capacity and ability to respond to infectious disease outbreaks.

29 Aug 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

Researchers propose a novel, non-discriminatory classification of the monkeypox virus

Researchers proposed a novel, non-discriminatory classification of the monkeypox virus.

29 Aug 2022

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.

28 Aug 2022

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines for the diagnosis and treatment of pulmonary hypertension, published online today in European Heart Journal and the European Respiratory Journal.

26 Aug 2022

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

26 Aug 2022

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Researchers evaluate infection rates and changes in the immunological history of COVID-19 patients over time.

25 Aug 2022

Investigating the links between the rate of new cases, mutations, and selection in SARS-CoV2 virus

How many times in the last 18 months have you seen a map that looks like the one above? It looks like a population density map, but in fact, it is a case total for the COVID19 rates from Johns Hopkins Coronavirus Research Center (collected on 24 May 2022).

25 Aug 2022

SARS-CoV-2 mutational spectra based on reconstructed phylogenetic tree

In a new study, researchers assessed the impact of mutagenesis on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome and the effects of mutations in the neutral regions and non-neutral regions of the genome.

25 Aug 2022

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In new research, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC).

25 Aug 2022

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers performed a systematic review and meta-analysis to investigate whether influenza vaccinations could reduce COVID-19 severity outcomes.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Influenza News and Research

Latest Influenza News and Research

How does origin impact antiviral immune response?

Analysis of the seasonality of common human coronaviruses

The currently available evidence on viral-induced parkinsonism

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

COVID-19 may provoke IgA-associated vasculitis

Disrupting a virus’s genome packaging can halt replication, study finds

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

Researchers propose a novel, non-discriminatory classification of the monkeypox virus

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

New guidelines recommend earlier detection and treatment of pulmonary hypertension

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Investigating the links between the rate of new cases, mutations, and selection in SARS-CoV2 virus

SARS-CoV-2 mutational spectra based on reconstructed phylogenetic tree

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in